STOCK TITAN
  1. Home
  2. IMLFF

InMed Pharms (IMLFF) Stock Price, News & Analysis

IMLFF OTC

Company Description

InMed Pharms (OTC: IMLFF) is classified in the biotechnology industry within the Health Technology sector.

This page collects what Stock Titan holds for IMLFF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
5.2M
Shares outstanding

Latest News

View All
—

InMed Announces Closing of US$4.5 Million Private Placement

private placement
—

InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results

earnings
—

InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results

conferences earnings
—

InMed Announces US$4.5 Million Private Placement

private placement

InMed Pharms has 4 recent news articles. Key topics include private placement, earnings, conferences. View all IMLFF news →

SEC Filings

View All

No SEC filings available for IMLFF.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMLFF Company Profile & Sector Positioning

InMed Pharms (IMLFF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.